サマリー

腎臓移植治療薬の世界市場2022-2026年
Technavioは腎臓移植治療薬市場を監視しており、2022-2026年の間に11億6000万ドルの成長が見込まれ、予測期間中にCAGR 4.32%で加速しています。当レポートでは、腎臓移植治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、CKDおよび腎障害の有病率の上昇、複数の剤形の薬剤の入手可能性、腎移植における免疫抑制剤への高い依存性によって推進されています。
腎臓移植治療薬市場の分析には、製品セグメントと地理的状況が含まれます。
Technavioの腎臓移植治療薬市場は、以下のように区分されています。
製品別
- 選択的サイトカイン阻害剤
- 免疫抑制性代謝拮抗薬
- その他の薬剤
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における腎臓移植治療薬市場の成長を促進する主な理由の一つとして、腎臓移植の新規技術を挙げています。また、腎臓移植の償還政策や戦略的提携の増加が、同市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。腎臓移植治療薬市場に関する当レポートは、以下の分野を対象としています。
- 腎臓移植治療薬市場のサイジング
- 腎臓移植治療薬市場の予測
- 腎臓移植治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、旭化成株式会社、アステラス製薬株式会社、B Braun Melsungen AG、Bristol Myers Squibb株式会社、ドクター・レディス研究所株式会社、F. Hoffmann La Roche Ltd. 、Fresenius Medical Care AG and Co.KGaA、GlaxoSmithKline Plc、Glenmark Pharmaceuticals Ltd.、Hansa Biopharma AB、Lifeline Scientific Inc、Novartis AG、Pfizer Inc、Preservation Solution Inc、Sanofi SA、Strides Pharma Science Ltd、TFF Pharmaceuticals Inc、TolerogenixX GmbHおよびTransonic Systems Inc.は、腎臓移植のための医薬品を開発するために必要な技術や知識を有しています。また、腎移植治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/kidney-transplantation-therapeutics-market-industry-size-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Selective cytokine inhibitors - Market size and forecast 2021-2026
o Exhibit 28: Chart on Selective cytokine inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Selective cytokine inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Selective cytokine inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Selective cytokine inhibitors - Year-over-year growth 2021-2026 (%)
o 5.4 Immunosuppressive antimetabolites - Market size and forecast 2021-2026
o Exhibit 32: Chart on Immunosuppressive antimetabolites - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Immunosuppressive antimetabolites - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Immunosuppressive antimetabolites - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Immunosuppressive antimetabolites - Year-over-year growth 2021-2026 (%)
o 5.5 Other drugs - Market size and forecast 2021-2026
o Exhibit 36: Chart on Other drug - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Other drug - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Other drug - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other drug - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share by geography 2021-2026 (%)
o Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity by geography
o Exhibit 86: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Asahi Kasei Corp.
o Exhibit 93: Asahi Kasei Corp. - Overview
o Exhibit 94: Asahi Kasei Corp. - Business segments
o Exhibit 95: Asahi Kasei Corp. - Key news
o Exhibit 96: Asahi Kasei Corp. - Key offerings
o Exhibit 97: Asahi Kasei Corp. - Segment focus
o 10.4 Astellas Pharma Inc.
o Exhibit 98: Astellas Pharma Inc. - Overview
o Exhibit 99: Astellas Pharma Inc. - Product / Service
o Exhibit 100: Astellas Pharma Inc. - Key news
o Exhibit 101: Astellas Pharma Inc. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 102: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 103: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 104: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 105: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 106: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 GlaxoSmithKline Plc
o Exhibit 107: GlaxoSmithKline Plc - Overview
o Exhibit 108: GlaxoSmithKline Plc - Business segments
o Exhibit 109: GlaxoSmithKline Plc - Key news
o Exhibit 110: GlaxoSmithKline Plc - Key offerings
o Exhibit 111: GlaxoSmithKline Plc - Segment focus
o 10.7 Glenmark Pharmaceuticals Ltd.
o Exhibit 112: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 113: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 114: Glenmark Pharmaceuticals Ltd. - Key offerings
o 10.8 Hansa Biopharma AB
o Exhibit 115: Hansa Biopharma AB - Overview
o Exhibit 116: Hansa Biopharma AB - Product / Service
o Exhibit 117: Hansa Biopharma AB - Key offerings
o 10.9 Novartis AG
o Exhibit 118: Novartis AG - Overview
o Exhibit 119: Novartis AG - Business segments
o Exhibit 120: Novartis AG - Key offerings
o Exhibit 121: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 122: Pfizer Inc. - Overview
o Exhibit 123: Pfizer Inc. - Product / Service
o Exhibit 124: Pfizer Inc. - Key news
o Exhibit 125: Pfizer Inc. - Key offerings
o 10.11 Sanofi SA
o Exhibit 126: Sanofi SA - Overview
o Exhibit 127: Sanofi SA - Business segments
o Exhibit 128: Sanofi SA - Key news
o Exhibit 129: Sanofi SA - Key offerings
o Exhibit 130: Sanofi SA - Segment focus
o 10.12 TFF Pharmaceuticals Inc.
o Exhibit 131: TFF Pharmaceuticals Inc. - Overview
o Exhibit 132: TFF Pharmaceuticals Inc. - Product / Service
o Exhibit 133: TFF Pharmaceuticals Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 134: Inclusions checklist
o Exhibit 135: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 136: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 137: Research methodology
o Exhibit 138: Validation techniques employed for market sizing
o Exhibit 139: Information sources
o 11.5 List of abbreviations
o Exhibit 140: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Selective cytokine inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Selective cytokine inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Selective cytokine inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Selective cytokine inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Immunosuppressive antimetabolites - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Immunosuppressive antimetabolites - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Immunosuppressive antimetabolites - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Immunosuppressive antimetabolites - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other drug - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other drug - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other drug - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other drug - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share by geography 2021-2026 (%)
Exhibits43: Data Table on Market share by geography 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity by geography ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Asahi Kasei Corp. - Overview
Exhibits94: Asahi Kasei Corp. - Business segments
Exhibits95: Asahi Kasei Corp. - Key news
Exhibits96: Asahi Kasei Corp. - Key offerings
Exhibits97: Asahi Kasei Corp. - Segment focus
Exhibits98: Astellas Pharma Inc. - Overview
Exhibits99: Astellas Pharma Inc. - Product / Service
Exhibits100: Astellas Pharma Inc. - Key news
Exhibits101: Astellas Pharma Inc. - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Overview
Exhibits103: F. Hoffmann La Roche Ltd. - Business segments
Exhibits104: F. Hoffmann La Roche Ltd. - Key news
Exhibits105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits106: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits107: GlaxoSmithKline Plc - Overview
Exhibits108: GlaxoSmithKline Plc - Business segments
Exhibits109: GlaxoSmithKline Plc - Key news
Exhibits110: GlaxoSmithKline Plc - Key offerings
Exhibits111: GlaxoSmithKline Plc - Segment focus
Exhibits112: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits113: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits114: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits115: Hansa Biopharma AB - Overview
Exhibits116: Hansa Biopharma AB - Product / Service
Exhibits117: Hansa Biopharma AB - Key offerings
Exhibits118: Novartis AG - Overview
Exhibits119: Novartis AG - Business segments
Exhibits120: Novartis AG - Key offerings
Exhibits121: Novartis AG - Segment focus
Exhibits122: Pfizer Inc. - Overview
Exhibits123: Pfizer Inc. - Product / Service
Exhibits124: Pfizer Inc. - Key news
Exhibits125: Pfizer Inc. - Key offerings
Exhibits126: Sanofi SA - Overview
Exhibits127: Sanofi SA - Business segments
Exhibits128: Sanofi SA - Key news
Exhibits129: Sanofi SA - Key offerings
Exhibits130: Sanofi SA - Segment focus
Exhibits131: TFF Pharmaceuticals Inc. - Overview
Exhibits132: TFF Pharmaceuticals Inc. - Product / Service
Exhibits133: TFF Pharmaceuticals Inc. - Key offerings
Exhibits134: Inclusions checklist
Exhibits135: Exclusions checklist
Exhibits136: Currency conversion rates for US$
Exhibits137: Research methodology
Exhibits138: Validation techniques employed for market sizing
Exhibits139: Information sources
Exhibits140: List of abbreviations